High Dose Radiation

RADIATION3 trials

Sponsors

Tata Memorial Hospital, University of Michigan Rogel Cancer Center, Glenn Bauman

Conditions

CholangiocarcinomaGliomaProstate Cancer

Phase 1

Radioligand fOr locAl raDiorecurrent proStaTe cancER

CompletedNCT05230251

Glenn BaumanProstate Cancer

Start: 2022-03-17End: 2024-12-31Updated: 2025-09-12

Phase 2

A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

CompletedNCT02805179

University of Michigan Rogel Cancer CenterGlioma

Start: 2016-09-22End: 2020-11-18Updated: 2021-04-15

Phase 3

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Tata Memorial HospitalCholangiocarcinoma

Start: 2015-05-31End: 2025-06-30Target: 155Updated: 2022-10-21

Related Papers

The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).

2023-04-207 citations

NIMG-63. SPATIAL CHARACTERIZATION OF 11C-METHIONINE PET AND HIGH B-VALUE DW-MRI TUMOR SUBREGIONS IN PATIENTS UNDERGOING BIOLOGICALLY-BASED DOSE-INTENSIFIED CHEMORADIATION ON A PHASE II CLINICAL TRIAL

Neuro-Oncology2017-11-01

Protocol for a phase III randomized trial of chemoradiation and systemic chemotherapy vs. systemic chemotherapy alone in patients with unresectable nonmetastatic cholangiocarcinoma

International Journal of Clinical Trials2017-01-251 citations